Inherited predisposition to early onset lung cancer according to histological type

International Journal of Cancer

Volumn 112, Issue 3, 2004, Pages 451-457

  Xinjun, L I ^a   Hemminki, Kari ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adenocarcinoma; Familial risk; Hereditary factors; Lung neoplasms; Squamous cell carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CONFIDENCE INTERVAL; DATA BASE; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; LARGE CELL CARCINOMA; LUNG CANCER; MALE; NEWBORN; PRIORITY JOURNAL; PROGENY; RECESSIVE GENE; SIBLING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; SIBLINGS; SMOKING; SWEDEN;

EID: 6344278732     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20436     Document Type: Article

References (49)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. IARC. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2001.
3. Centre for Epidemiology. Cancer incidence in Sweden 2000. Stockholm: The National Board of Health and Welfare, 2002.
4. Lagarde F, Axelsson G, Damber L, Mellander H, Nyberg F, Pershagen G. Residential radon and lung cancer among never-smokers in Sweden. Epidemiology 2001;12:396-404.
5. Pohlabeln H, Boffetta P, Ahrens W, Merletti F, Agudo A, Benhamou E, Benhamou S, Bruske-Hohlfeld I, Ferro G, Fortes C, Kreuzer M, Mendes A, et al. Occupational risks for lung cancer among nonsmokers. Epidemiology 2000;11:532-8.
6. Li X, Mutanen P, Hemminki K. Gender-specific incidence trends in lung cancer by histological type in Sweden, 1958-1996. Eur J Cancer Prev 2001;10:227-35.
7. Zheng T, Holford TR, Boyle P, Chen Y, Ward BA, Flannery J, Mayne ST. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989. Cancer 1994;74:1556-67.
8. Levi F, Franceschi S, La Vecchia C, Randimbison L, Te VC. Lung carcinoma trends by histologic type in Vaud and Neuchatel, Switzerland, 1974-1994. Cancer 1997;79:906-14.
9. Mabry M, Nelkin BD, Baylin SB. Lung cancer. In: Bert Vogelstein, Kenneth W. Kinzler, eds. The genetic basis of human cancer. New York: McGraw-Hill, 1998.
10. Yang P, Schwartz AG, McAllister AE, Aston CE, Swanson GM. Genetic analysis of families with nonsmoking lung cancer probands. Genet Epidemiol 1997;14:181-97.
11. Gauderman WJ, Morrison JL, Carpenter CL, Thomas DC. Analysis of gene-smoking interaction in lung cancer. Genet Epidemiol 1997;14: 199-214.
12. Sellers TA, Weaver TW, Phillips B, Altmann M, Rich SS. Environmental factors can confound identification of a major gene effect: results from a segregation analysis of a simulated population of lung cancer families. Genet Epidemiol 1998;15:251-62.
13. Hussain SP, Hofseth LJ, Harris CC. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer 2001;34 Suppl 2:S7-15.
14. Fong KM, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med 2002;23:83-101.
15. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 2003;32:60-3.
16. Nair U, Bartsch H. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ 2001;154:271-90.
17. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
18. Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003;24:875-82.
19. Law MR. Genetic predisposition to lung cancer. Br J Cancer 1990; 61:195-206.
20. Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76: 217-22.
21. Manenti G, Nomoto T, De Gregorio L, Gariboldi M, Stefania Falvella F, Nagao M, Dragani TA. Predisposition to lung tumorigenesis. Toxicol Lett 2000;112-113:257-63.
22. Manenti G, Acevedo A, Galbiati F, Gianni Barrera R, Noci S, Salido E, Dragani TA. Cancer modifier alleles inhibiting lung tumorigenesis are common in inbred mouse strains. Int J Cancer 2002;99:555-9.
23. Stayner LT. Wegman DH. Smoking, occupation, and histopathology of lung cancer: a case-control study with the use of the Third National Cancer Survey. J Natl Cancer Inst 1983;70:421-6.
24. Ambrosone CB, Rao U, Michalek AM, Cummings KM, Mettlin CJ. Lung cancer histologic types and family history of cancer. Analysis of histologic subtypes of 872 patients with primary lung cancer. Cancer 1993;72:1192-8.
25. Sellers TA, Elston RC, Atwood LD, Rothschild H. Lung cancer histologic type and family history of cancer. Cancer 1992;69:86-91.
26. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nationwide Swedish Family-Cancer Database: updataed structure and familial rates. Acta Oncol 2001;40:772-77.
27. Hemminki K, Vaittinen P, Kyyronen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer 1998;78:172-5.
28. Hemminki K, Vaittinen P, Kyyronen P. Modification of cancer risk in offspring by parental cancer (Sweden). Cancer Causes Control 1999; 10:125-9.
29. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;92:144-50.
30. Hemminki K, Granström C. Risk for familial breast cancer increases with age. Nature Genet 2002;32:233.
31. Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer 2003;103:105-9.
32. Hemminki K, Zhang H, Czene K. Socioeconomic factors in cancer in Sweden. Int J Cancer 2003;105:692-700.
33. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research, Vol IV; descriptive epidemiology. IARC Sc Publ 1994;128:1-302.
34. Hemminki K, Vaittinen P, Dong C. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 2001;84:388-91.
35. dos Santos Silva I. Cancer Epidemiology: principles and methods. Lyon: IARC, 1999.
36. Armitage P, Berry G. Statistical methods in medial research, 3rd ed. Blackwell: Oxford, 1994.
37. Wood ME, Kelly K, Mullineaux LG, Bunn PA, Jr. The inherited nature of lung cancer: a pilot study. Lung Cancer 2000;30:135-44.
38. Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002; 11:1638-44.
39. Hemminki K, Jiang Y. Cancer risks among long-standing spouses. Br J Cancer 2002;86:1737-40.
40. Lichtensteiri P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
41. Hemminki K, Lonnstedt I, Vaittinen P, Lichtenstein P. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet Epidemiol 2001;20:107-16.
42. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002;99:260-6.
43. Hemminki K, Li X. Gender effects in familial cancer. Int J Cancer 2002;102:184-7.
44. Sellers TA, Chen PL, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC. Segregation analysis of stnoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet 1994;52:308-14.
45. Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 1999;17:253-73.
46. Gauderman WJ, Morrison JL. Evidence for age-specific genetic relative risks in lung cancer. Am J Epidemiol 2000;151:41-9.
47. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, Della Porta G, Binelli G, Dragani TA. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet 1993;3:132-6.
48. Manenti G, Stafford A, De Gregorio L, Gariboldi M, Falvella FS, Avner P, Dragani TA. Linkage disequilibrium and physical mapping of Pas1 in mice. Genome Res 1999;9:639-46.
49. Kumar V, Cotran R, Robbins S. Basic pathology: Philadelphia: W.B. Saunders, 1997.